These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 9812066)

  • 1. Post hoc subgroup analysis and the truth of a clinical trial.
    Adams KF
    Am Heart J; 1998 Nov; 136(5):753-8. PubMed ID: 9812066
    [No Abstract]   [Full Text] [Related]  

  • 2. Statistical trial designs and clinical practice: are they compatible?
    Punt CJ
    Onkologie; 2003 Dec; 26(6):518-9. PubMed ID: 14709922
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized consent designs for clinical trials: an update.
    Ellenberg SS
    Stat Med; 1992 Jan; 11(1):131-2. PubMed ID: 1557570
    [No Abstract]   [Full Text] [Related]  

  • 4. The case against independent monitoring committees.
    Harrington D; Crowley J; George SL; Pajak T; Redmond C; Wieand S
    Stat Med; 1994 Jul 15-30; 13(13-14):1411-4. PubMed ID: 7973220
    [No Abstract]   [Full Text] [Related]  

  • 5. Statistical management of data in clinical research.
    Fleiss JL; Kingman A
    Crit Rev Oral Biol Med; 1990; 1(1):55-66. PubMed ID: 2101261
    [No Abstract]   [Full Text] [Related]  

  • 6. Is Propensity Score Analysis a Valid Surrogate of Randomization for the Avoidance of Allocation Bias?
    Torres F; Ríos J; Saez-Peñataro J; Pontes C
    Semin Liver Dis; 2017 Aug; 37(3):275-286. PubMed ID: 28847037
    [No Abstract]   [Full Text] [Related]  

  • 7. University of Pennsylvania 11th annual conference on statistical issues in clinical trials: Estimands, missing data and sensitivity analysis (afternoon panel session).
    Little RJ; Tchetgen EJT; Troxel AB
    Clin Trials; 2019 Aug; 16(4):381-390. PubMed ID: 31244326
    [No Abstract]   [Full Text] [Related]  

  • 8. Dropouts and missing data in psychiatric clinical trials.
    Potkin SG; Siu CO
    Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237
    [No Abstract]   [Full Text] [Related]  

  • 9. An overview of statistical and regulatory issues in the planning, analysis, and interpretation of subgroup analyses in confirmatory clinical trials.
    Hemmings R
    J Biopharm Stat; 2014; 24(1):4-18. PubMed ID: 24392975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive designs from the viewpoint of an academic biostatistician.
    Schäfer H
    Biom J; 2006 Aug; 48(4):586-90; discussion 613-22. PubMed ID: 16972709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-hoc data analysis: benefits and limitations.
    Curran-Everett D; Milgrom H
    Curr Opin Allergy Clin Immunol; 2013 Jun; 13(3):223-4. PubMed ID: 23571411
    [No Abstract]   [Full Text] [Related]  

  • 12. Sources of bias in clinical trials.
    Pandis N
    Am J Orthod Dentofacial Orthop; 2011 Oct; 140(4):595-6. PubMed ID: 21967950
    [No Abstract]   [Full Text] [Related]  

  • 13. Defining treatment effects: A regulatory perspective.
    Permutt T
    Clin Trials; 2019 Aug; 16(4):345-349. PubMed ID: 30764658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research.
    Freemantle N; Marston L; Walters K; Wood J; Reynolds MR; Petersen I
    BMJ; 2013 Nov; 347():f6409. PubMed ID: 24217206
    [No Abstract]   [Full Text] [Related]  

  • 15. Interpretation of clinical trial results.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S114-20. PubMed ID: 19007606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misuse of baseline comparison tests and subgroup analyses in surgical trials.
    Bhandari M; Devereaux PJ; Li P; Mah D; Lim K; Schünemann HJ; Tornetta P
    Clin Orthop Relat Res; 2006 Jun; 447():247-51. PubMed ID: 16672904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trials or population-based registries.
    Bergqvist D; Björck M; Säwe J; Troëng T
    Eur J Vasc Endovasc Surg; 2007 Sep; 34(3):253-6. PubMed ID: 17689818
    [No Abstract]   [Full Text] [Related]  

  • 18. General guidance on exploratory and confirmatory subgroup analysis in late-stage clinical trials.
    Dmitrienko A; Muysers C; Fritsch A; Lipkovich I
    J Biopharm Stat; 2016; 26(1):71-98. PubMed ID: 26366479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stopping trials for efficacy: an almost unbiased view.
    Goodman SN
    Clin Trials; 2009 Apr; 6(2):133-5. PubMed ID: 19342465
    [No Abstract]   [Full Text] [Related]  

  • 20. Subgroup analyses.
    Oxman AD
    BMJ; 2012 Mar; 344():e2022. PubMed ID: 22422834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.